丽珠医药(01513)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01513 丽珠医药

未开盘 08-18 16:08:05

25.040

-0.260

-1.03%

最高25.440	最低25.040	成交量45.24万
今开25.440	昨收25.300	日振幅1.58%
总市值222.36亿	流通市值75.12亿	总股本8.88亿
成交额1,137万	换手率0.15%	流通股本3.00亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01513","market":"HK","secType":"STK","nameCN":"丽珠医药","latestPrice":25.04,"timestamp":1787040485003,"preClose":25.3,"halted":0,"volume":452394,"delay":0,"changeRate":-0.010276679841897295,"floatShares":300000000,"shares":888000000,"eps":2.639148972884786,"marketStatus":"未开盘","change":-0.26,"latestTime":"08-18 16:08:05","open":25.44,"high":25.44,"low":25.04,"amount":11369588,"amplitude":0.01581,"askPrice":25.1,"askSize":43000,"bidPrice":25.04,"bidSize":1800,"shortable":3,"etf":0,"ttmEps":2.562603189084891,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787103000000},"marketStatusCode":0,"adr":0,"listingDate":1389801600000,"exchange":"SEHK","adjPreClose":25.3,"dividendRate":0.065575,"openAndCloseTimeList":[[1787016600000,1787025600000],[1787029200000,1787040000000]],"volumeRatio":0.622115766351613,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"000513","market":"SZ","secType":"STK","nameCN":"丽珠集团","latestPrice":29.72,"timestamp":1787036400000,"preClose":30.05,"halted":0,"volume":5017700,"delay":0,"premium":"-27.53"}},"requestUrl":"/m/hq/s/01513","defaultTab":"news","newsList":[{"id":"2660346335","title":"港股收评：恒指国指午后转涨，猪肉、海运板块全天活跃，阿里急涨5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660346335","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660346335?lang=zh_cn&edition=full","pubTime":"2026-08-18 16:37","pubTimestamp":1787042222,"startTime":"0","endTime":"0","summary":"受阿里巴巴等权重科网股拉升带动，港股午后走势回暖，恒生指数与国企指数由跌转涨至0.07%及0.16%，二者延续昨日反弹行情，恒生科技指数则收跌0.9%，盘中曾大跌2.2%。另一方面，受外围芯片股大涨带动高开的存储半导体、光通信、PCB板块呈现低迷行情，南方两倍做多三星电子大跌超10%，建滔积层板跌超8%，华虹宏力尾盘出现跳水行情收跌近8%，AI应用概念股、保险股、风电股、航空股、有色金属股齐跌。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260818/32338544.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU1048588211.SGD","LU0499858438.USD","LU1515016050.SGD","BK1502","CXSE","LU1044876610.USD","LU1880383440.USD","LU0327786744.USD","LU0516423174.USD","LU0348825331.USD","LU0634319403.HKD","LU2097828805.USD","LU0228367735.SGD","LU0640798160.USD","IE00BMPRXR70.SGD","FDNI","LU2125910500.SGD","03419","LU1196710864.SGD","LU0130103400.USD","BK1610","LU0259732245.USD","LU0630378429.USD","LU0164872284.USD","LU1303224171.USD","LU0577902371.SGD","LU0823039010.USD","LU0477156797.USD","LU0348827113.USD","LU2097828474.EUR","LU0449509016.USD","LU1655091459.SGD","HBBD.SI","LU0607220059.USD","HK0000151867.HKD","LU1568876335.HKD","LU0543330483.HKD","LU0173614495.USD","LU0823413660.USD","LU0011963245.USD","LU1201861165.SGD","LU1224444064.USD","LU0791591158.USD","01051","07552","LU1960683339.HKD","LU0254981946.USD","LU1316542783.SGD","LU1481107354.HKD","LU0359201612.USD","LU0417516738.SGD","LU0871576103.HKD","LU0762540952.USD","LU0348788117.USD","LU0345775950.USD","LU1642822792.SGD","LU1282649810.SGD","LU0979878070.USD","LU0359201885.HKD","HK0000320223.HKD","HK0000320264.USD","LU0823038988.USD","000513","LU0762542818.HKD","LU2097828631.EUR","SGXZ86797644.SGD","LU0054237671.USD","LU2399975544.HKD","LU0061477393.USD","LU0329678337.USD","SG9999004220.SGD","LU0261950983.USD","LU0608807946.USD","LU0469268626.HKD","IE0003895053.USD","LU0197773160.USD","IE00BZ08YS42.EUR","LU2039709279.SGD","LU0737861772.HKD","LU0143863784.USD","LU0132412106.USD","LU0651946864.USD","BK1618","LU0762541174.USD","LU1282649141.HKD","LU0307460666.USD","LU0543330566.HKD","LU0181495838.USD","LU0823041008.USD","BK1586","LU1044874839.SGD","IE00BZ08YT58.USD","SG9999006597.SGD","82800","07300","LU0370786039.SGD","LU0531971595.HKD","LU0865486749.SGD","LU1188198961.HKD","LU0502904849.HKD","LU0605514214.HKD","BKF","LU1242518931.SGD","LU2294711473.HKD","BK1208","BK1608","HSTECH","LU0231483743.USD","IE00B0JY6N72.USD","LU0588545490.SGD","LU1323998911.USD","LU0210527791.USD","LU0823426480.USD","09988","LU0589944569.HKD","ALBmain","LU1993786604.SGD","LU0348735423.USD","LU0165289439.USD","LU0417516902.SGD","MCHmain","LU0106959298.USD","LU0516422952.EUR","BK1588","LU0516422440.USD","LU0541502299.USD","03115","LDEM","LU0128522157.USD","LU1769817096.USD","LU0594300419.USD","LU0531970944.HKD","SG9999006514.SGD","BK1570","LU1810669033.SGD","LU0229945570.USD","LU0314109678.HKD","LU1831875114.USD","SG9999000459.SGD","SG9999000327.SGD","LU1720051108.HKD","LU0823397285.USD","IE00B543WZ88.USD","02828","LU0488056044.USD","LU1868838027.USD","LU0577902454.USD","LU0541501648.USD","LU0821914370.USD","LU0886674414.USD","07500","LU0315178854.USD","LU0214875030.USD","LU1282649067.USD","LU0235996351.USD","LU1282651048.USD","LU1770034418.SGD","LU0868486357.SGD","LU0348784397.USD","LU0708995583.HKD","LU0348783233.USD","LU1813983027.USD","LU0052750758.USD","BK1521","07226","LU0611395673.USD","SG9999001093.SGD","LU0831103253.SGD","07288","BK1517","LU3063872942.SGD","LU0823040885.USD","LU0348783662.USD","LU2449936058.SGD","LU0106259558.USD","LU0431992006.USD","LU0672654166.SGD","LU0197773673.USD","03417","LU2476274308.USD","LU0828237940.HKD","02833","LU1770036033.HKD","LU0456846285.SGD","LU0648000940.SGD","LU0516422366.SGD","LU1868837565.USD","SGXZ90724238.SGD","LU0784639295.USD","HK0000306701.USD","LU0328353924.USD","BK1575","HSCEI","LU1224709979.USD","LU0463099449.HKD","LU2778985437.USD","LU0140636845.USD","09088","LU0577902538.SGD","LU1719994722.HKD","LU0737861699.HKD","LU0384037296.USD","HK0000306685.HKD","SGXZ62798434.SGD","KWEB","07200","LU1242518857.USD","LU0117841782.USD","LU1961090484.USD","LU0149534421.HKD","LU0326950275.SGD","LU0029875118.USD","LU0320764755.SGD","LU0264606111.USD","LU0169518387.USD","HK0000286598.CNH","LU2125910849.SGD","LU1880383366.USD","LU0049853897.USD","83115","LU0048580855.USD","HHImain","IE0034224299.USD","03067","LU0819123356.HKD","LU0608807433.USD","LU1439103000.SGD","03416","LU0873338254.USD","LU0831093199.SGD","LU0211977185.USD","LU0890818403.SGD","89988","LU0048597586.USD","LU0345776255.USD","LU0862451837.USD","LU0823397103.USD","LU0862451753.SGD","LU0293314216.USD","LU0039217434.USD","LU1720051017.SGD","LU1688375341.USD","BK1249","09115","LU0455707207.USD","LU0228659784.USD","01513","LU0630378692.HKD","LU0315179316.USD","LU0106252389.USD","LU0329678170.USD","LU0588545730.USD","LU0072462343.USD","07747","LU0029874905.USD","BK1615","LU1115378108.SGD","LU2257852520.SGD","IE00B0169N27.USD","82828","IE00B5MMRT66.SGD","BK1584","LU0164880469.USD","LU0456827905.SGD","LU0588546209.SGD","LU0594300179.USD","02837","LU0210526637.USD","LU0163747925.USD","LU0516423091.SGD","LU1211504680.USD","BK1142","LU0417516571.SGD","LU0791590937.USD","SG9999002463.SGD","SG9999001689.USD","LU0051755006.USD","LU1956131251.USD","SG9999001226.SGD","LU0084288322.USD","LU1548497426.USD","LU1807302812.USD","LU0130518102.USD","LU0096374516.USD","07588","LU1051768304.USD","LU1366334651.USD","LU0588545904.SGD","LU2097828557.USD","LU0251144936.SGD","LU0650527681.SGD","LU0127658192.USD","02800","LU2097828714.EUR","LU0700851271.USD","LU1328615791.USD","LU0856984785.SGD","LU0819121731.USD","LU2087589342.USD","LU2045819591.USD","LU1044875133.USD","LU1880398471.USD","LU0320764599.SGD","LU2097829019.USD","LU1808992512.USD","IE0032431581.USD","IE00BPRC5H50.USD","03037","LU0577902611.USD","LU0449515922.USD","LU1251922891.USD","LU2152927971.USD","LU0651947912.USD","03423","LU0572940350.SGD","LU0054450605.USD","LU2357305700.SGD","LU0048388663.USD","LU0572939691.SGD","LU0441854154.USD","LU0823426308.USD","03033","LU1504937902.USD","BK1191","LU1051769294.HKD","LU0396098781.USD","LU0675040207.SGD","SG9999001051.SGD","LU0261947096.USD","LU0196878994.USD","LU0572944931.SGD","IE00B3M56506.USD","LU1023057109.AUD","HK0000107257.USD","LU2242644610.SGD","IE0008368304.USD","LU0164865239.USD","LU0047713382.USD","LU1880398554.USD","513600","LU0828237510.HKD","SG9999001903.USD","HSI","LU1048596156.SGD","LU0348805143.USD","LU0561508036.HKD","SG9999002828.SGD","SG9999014674.SGD","LU1568876251.USD","LU1048484197.HKD","LU0642271901.SGD","LU0823413587.USD","IE00BMPRXN33.USD","LU0898667661.SGD","LU0149721374.USD","LU0708995153.HKD","LU1981816686.USD","BK1591","BK1209","LU0593848301.USD","LU0244354667.USD","03088","BABA","LU1769817179.HKD","09067","LU0577902298.EUR","LU2476274720.SGD","LU0117844026.USD","03032","LU2293587155.HKD","LU0540923850.HKD","LU1328277881.USD","IE00BZ08YR35.GBP","LU0128522744.USD","LU0359202008.SGD","LU0499858602.USD","LU0043850808.USD","SG9999002562.SGD","LU1282651121.HKD","LU1794554557.SGD","LU0287142896.SGD","BK1501","LU0143863198.USD","LU0648948544.HKD","LU1720050803.USD","LU1366334578.USD","LU2488822045.USD","01515","LU0320764243.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123427525","title":"财报前瞻 ｜丽珠医药本季营收预计下滑5.79%，机构观点偏正面","url":"https://stock-news.laohu8.com/highlight/detail?id=1123427525","media":"财报Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://www.laohunote.com/m/news/1123427525?lang=zh_cn&edition=full","pubTime":"2026-08-14 08:38","pubTimestamp":1786667902,"startTime":"0","endTime":"0","summary":"丽珠医药将于2026年08月21日盘后披露上半年业绩，市场关注收入节奏、利润率韧性与新品放量路径。市场一致预期本季度公司营业收入约为29.53亿元，同比下降5.79%；调整后每股收益约0.64元，同比增长12.28%；息税前利润约为6.98亿元，同比增长1.12%；公司未披露本季度的毛利率与净利润或净利率预测。上一季度公司实现营业收入28.71亿元，同比下降9.74%；毛利率65.87%；归属于母公司股东的净利润5.77亿元，净利率20.09%；调整后每股收益0.65元，同比下降8.45%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报前瞻 ｜丽珠医药本季营收预计下滑5.79%，机构观点偏正面","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185649162","title":"丽珠医药（01513）将于2026年8月21日召开董事会审议上半年业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1185649162","media":"公告速递","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1185649162?lang=zh_cn&edition=full","pubTime":"2026-08-06 16:56","pubTimestamp":1786006561,"startTime":"0","endTime":"0","summary":"丽珠医药集团股份有限公司8月6日公告，公司董事会已决定于2026年8月21日（星期五）召开董事会会议，主要议程包括：。香港交易及结算所有限公司及香港联合交易所有限公司就本公告内容概不负责，并对其准确性或完整性不作任何声明。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198198471","title":"丽珠医药集团新增6.52亿元对子公司融资性担保 累计担保余额达16.54亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1198198471","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198198471?lang=zh_cn&edition=full","pubTime":"2026-08-04 21:36","pubTimestamp":1785850561,"startTime":"0","endTime":"0","summary":"2026年8月5日，丽珠医药集团股份有限公司公告披露，为满足子公司经营发展需要，公司于2026年7月先后与交通银行珠海分行、中国工商银行珠海分行签订《担保合同》及《最高额保证合同》，合计新增连带责任保证担保额度65,200.00万元。根据公司于2026年3月24日董事会及2026年5月29日股东会通过的相关议案，丽珠医药集团2026年度拟为合并报表范围内子公司提供累计不超过1,167,825.00万元或等值外币的融资性担保。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100370816","title":"丽珠医药2026年7月股份变动月报：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1100370816","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100370816?lang=zh_cn&edition=full","pubTime":"2026-08-03 16:43","pubTimestamp":1785746636,"startTime":"0","endTime":"0","summary":"丽珠医药集团股份有限公司于2026年8月3日披露了截至2026年7月31日的股份变动月报表。报告期为2026年7月1日至2026年7月31日。公司已发行股份方面：截至2026年7月末，香港上市H股普通股股本数量保持299,807,117股，A股普通股股本数量保持588,100,054股，合计已发行股本为887,907,171股，较上月底无增减变动。公司未披露任何股份期权计划变动、可转债转股或其他股份协议签署。截至2026年7月31日，公司总体股本规模保持不变，公众持股部分符合相关最低要求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148769878","title":"丽珠医药（01513）首款中药3.1类新药获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=1148769878","media":"公告速递","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1148769878?lang=zh_cn&edition=full","pubTime":"2026-07-23 19:36","pubTimestamp":1784806573,"startTime":"0","endTime":"0","summary":"2026年7月24日，丽珠医药集团股份有限公司公告称，其子公司四川光大制药有限公司收到国家药监局签发的《药品注册证书》。获批药品为半夏白术天麻汤颗粒，注册分类为中药3.1类，证书编号2026S02612，批准文号国药准字C20260019，有效期至2031年7月20日。公司披露，截至公告日，半夏白术天麻汤颗粒的累计直接研发投入约501.02万元。丽珠医药表示，该品种为公司首款获批上市的中药3.1类新药，将丰富产品管线；因刚获批上市，预计对近期经营业绩影响有限。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653966742","title":"丽珠医药(01513)：半夏白术天麻汤颗粒获《药品注册证书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2653966742","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653966742?lang=zh_cn&edition=full","pubTime":"2026-07-23 19:34","pubTimestamp":1784806462,"startTime":"0","endTime":"0","summary":"智通财经APP讯，丽珠医药 发布公告，近日，公司的子公司四川光大制药有限公司就半夏白术天麻汤颗粒的药品注册申请收到国家药品监督管理局签发的《药品注册证书》。该药品处方源自清代程国彭所著《医学心悟》，已列入国家中医药管理局《古代经典名方目录(第一批)》。截至本公告披露日，半夏白术天麻汤颗粒累计直接投入的研发费用约为人民币501.02万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1471577.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"丽珠医药(01513)：半夏白术天麻汤颗粒获《药品注册证书》","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144435668","title":"丽珠医药发布6月股份变动月报表，股本结构保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1144435668","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1144435668?lang=zh_cn&edition=full","pubTime":"2026-07-02 16:53","pubTimestamp":1782982389,"startTime":"0","endTime":"0","summary":"2026年7月2日，丽珠医药集团股份有限公司发布截至2026年6月30日的股份变动月报表。公告显示，丽珠医药本月法定/注册股本 总额为人民币887,907,171元。上述两类股份在报告期内无增减变动。已发行H股本月维持在299,807,117股，已发行A股本月维持在588,100,054股；两类股份本期内無新增发行与购回，亦无注销或库藏股变动。上述数据表明，截至6月末，公司的股本规模保持稳定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642844597","title":"港股异动 | 丽珠医药(01513)尾盘涨近4% 莱康奇塔单抗注射液上市许可申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2642844597","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2642844597?lang=zh_cn&edition=full","pubTime":"2026-06-10 15:31","pubTimestamp":1781076702,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，丽珠医药(01513)尾盘涨近4%，截至发稿，涨3.62%，报26.34港元，成交额1849.09万港元。消息面上，丽珠集团近日宣布，其1类创新生物药莱康奇塔单抗用于治疗强直性脊柱炎的上市申请，已获国家药品监督管理局正式受理。这是该药物继银屑病适应症上市申请获受理并纳入优先审评后，斩获的第二项 NDA 受理。公开资料显示，莱康奇塔单抗是中国首个自主研发的IL-17A/F双抗。随着后续适应症的逐步获批，莱康奇塔单抗将进一步丰富丽珠医药在自免领域的产品矩阵，提升公司在全球生物医药市场的竞争力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452494.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VXUS","IPOS","BK4588","01513","BK1191","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640995865","title":"港股公告掘金 | 智谱拟发行A股并在科创板上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2640995865","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640995865?lang=zh_cn&edition=full","pubTime":"2026-06-02 09:00","pubTimestamp":1780362051,"startTime":"0","endTime":"0","summary":"重大事项：丽珠医药：重组人促卵泡激素注射液获得《药品注册证书》山东新华制药股份：获得碳酸司维拉姆干混悬剂药品注册证书白云山：白云山制药总厂收到国家药监局核准签发的关于磷酸奥司他韦干混悬剂的《药品注册证书》智谱拟发行A股并在科创板上市驭势科技：与赛力斯凤凰智创完成行泊一体乘用车海外量产及交付澜起科技：横琴公司拟进行增资扩股并引入新投资方 引资合共约5亿元股东持续赋能!","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448875.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00874","00719","LU0650527681.SGD","00175","LU1960683339.HKD","LU0326948709.USD","LU0455707207.USD","LU0499858438.USD","BK1606","LU0856984785.SGD","LU0128522157.USD","LU1831875114.USD","BK1509","BK1221","LU0823426308.USD","LU0979878070.USD","LU1808992512.USD","LU0469268626.HKD","LU0516423091.SGD","LU0819123356.HKD","LU2476274308.USD","LU2125910500.SGD","LU2294711713.HKD","LU1868838027.USD","09973","02886","LU0417516902.SGD","LU1064131003.USD","LU1102505762.USD","000756","LU0211977185.USD","LU0594300419.USD","LU0611395673.USD","LU0259732245.USD","LU2097828474.EUR","LU0054237671.USD","IE00BZ08YR35.GBP","LU0540923850.HKD","SG9999000327.SGD","LU0067412154.USD","LU2360107325.USD","LU0823039010.USD","LU0511384066.AUD","LU0289961442.SGD","LU0918141705.HKD","LU0531971595.HKD","LU1770034418.SGD","06809","LU0128522744.USD","LU1675838814.USD","LU1303224171.USD","LU2148510915.USD","80175","LU0043850808.USD","LU0700851271.USD","02513","BK1618","LU1102505929.USD","BK1191","LU0164865239.USD","LU1861214812.USD","LU0589944569.HKD","LU1188198961.HKD","LU0293314216.USD","LU0327786744.USD","BK1575","LU0072913022.USD","GELYY","LU0359201612.USD","LU0737861699.HKD","LU0463099449.HKD","HMTD.SI","BK1583","LU0054450605.USD","LU0531970944.HKD","BK1591","LU0181495838.USD","LU0708995583.HKD","LU0029874905.USD","XPEV","LU0588545490.SGD","LU2087589342.USD","LU0823414478.USD","LU0231483743.USD","09866","LU0048580855.USD","LU2097828714.EUR","LU0143863784.USD","LU1323998911.USD","LU0797268264.HKD","LU2249611893.SGD","LU2097828557.USD","LU2476274720.SGD","LU0051755006.USD","BK1615","01513","LU0823040885.USD","LU1813983027.USD","LU1868837565.USD","LU0509642566.USD","LU0821914370.USD","SG9999002828.SGD","IE0008369823.USD","LU0577902454.USD","BK1197","LU0370786039.SGD","LU2039709279.SGD","09927","LU0449509016.USD","LU0577902371.SGD","LU0828238088.HKD","02333","BK1515","BK1587","IE00B031HY20.USD","LU1023057109.AUD","LU2242644610.SGD","IE0034224299.USD","LU0359201885.HKD","LU1282648689.USD","LU2348774022.SGD","LU1720050803.USD","LU0823041008.USD","LU1152091754.HKD","LU2257852520.SGD","82333","LU0196878994.USD","LU1688375341.USD","LU0516422366.SGD","LU1807302812.USD","NIO.SI","NIO","LU0634319403.HKD","LU0117841782.USD","LU0828237510.HKD","LU0011963245.USD","LU0084288322.USD","SG9999015986.USD","LU2153592121.USD","LU0672654166.SGD","LU0261950983.USD","LU0593848301.USD","LU0072462343.USD","EVS.SI","LU2488822045.USD","IE0032431581.USD","LU1719994722.HKD","LU0516423174.USD","IE00B0JY6N72.USD","LU0819121731.USD","LU0307460666.USD","BK1540","LU0348788117.USD","LU2449936058.SGD","LU0577902611.USD","LU0359202008.SGD","LU0577902298.EUR","LU0823414551.USD","LU0251144936.SGD","LU1242518857.USD","LU0449515922.USD","SG9999002562.SGD","LU0348827113.USD","IE00B5MMRT66.SGD","LU1880383366.USD","LU0594300179.USD","LU0502904849.HKD","LU1008478684.HKD","LU0320764599.SGD","LU0878005551.USD","LU0348825331.USD","BK1582","LU0314109678.HKD","LU2152927971.USD","LU0541502299.USD","002594","LU0315179316.USD","LU0588545904.SGD","IE00BF5LJ272.USD","SG9999001226.SGD","LU0047713382.USD","LU1064130708.USD","IE00BPRC5H50.USD","LU1251922891.USD","LU0543330566.HKD","LU0140636845.USD","BK1588","LU1328277881.USD","LU0348735423.USD","LU1048596156.SGD","LU0823038988.USD","IE0008368742.USD","BK1539","BK1594","LU1224709979.USD","LU0572944931.SGD","LU0588546209.SGD","LU2399975544.HKD","07489","LU0149721374.USD","LU0049853897.USD","LU2506951792.HKD","LU0516422440.USD","LU0577902538.SGD","600332","09868","LU1152091168.USD","LU0229945570.USD","LU0345775950.USD","LU0029875118.USD","LU0871576103.HKD","LU0164880469.USD","LU0287142896.SGD","LU0873338254.USD","601633","LU0345776255.USD","LU0561508036.HKD","LU0348816934.USD","BK1604","SG9999015952.SGD","81211","IE00BZ08YS42.EUR","LU1880383440.USD","SG9999015945.SGD","LU1868837722.USD","BK1522","LU0348814723.USD","LU0541501648.USD","LU0633140727.USD","LU0683595622.HKD","LU0320764243.SGD","LU0431992006.USD","BK1233","03690","LU0214875030.USD","LU0605514214.HKD","SG9999000459.SGD","LU2357125470.USD","LU2778985437.USD","HYDD.SI","LU0865486749.SGD","LU0456846285.SGD","LU0708995153.HKD","LU1794554557.SGD","688008","LU0501845795.SGD","LU0165289439.USD","LU0106252389.USD","LU1282651121.HKD","LU0048597586.USD","SG9999001903.USD","IE00BZ08YT58.USD","IE00B3M56506.USD","BK1119","LU0417516738.SGD","LU1105468828.SGD","LU1282651048.USD","LU1734074674.USD","LU1224444064.USD","SG9999002463.SGD","SG9999014674.SGD","LU0289960550.SGD","LU0210526637.USD","METmain","LU0244354667.USD","BYDDY","LU0828237940.HKD","LU1961090484.USD","SG9999001689.USD","LU0348805143.USD","LU1048588211.SGD","LU0543330483.HKD","LU2045819591.USD","BK1610","01211","LU0320764755.SGD","LU0588545730.USD","IE00BD6J9T35.USD","000513","BK1117","LU0228659784.USD","LU1861219969.SGD","LU0823426480.USD","LU1328615791.USD","LU0039217434.USD","LU0499858602.USD","LU0173614495.USD","LU0880133367.SGD","LU0918141887.USD","LU1226287529.USD","LU0052750758.USD","LU2097828631.EUR","601127","LU2097828805.USD","SG9999015978.USD","LU0633140560.USD","LU1481107354.HKD","BK1163","LU0868486357.SGD","LU1242518931.SGD","BK1521","LU0456827905.SGD","LU0505663152.USD","BK1589","LU1993786604.SGD","BK1142","IE00B543WZ88.USD","LU0164872284.USD","LU0315178854.USD","LU0132412106.USD","LU0269904917.USD","LU0143863198.USD","LU0254981946.USD","LU1770036033.HKD","SG9999006514.SGD","MPNGY","IE00B29SXG58.USD","LU2226246903.HKD","LU0175139822.USD","01511","LU0289739343.SGD","GWLLY","LU0326950275.SGD","SG9999006597.SGD","LU0516422952.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640957430","title":"丽珠医药(01513)：重组人促卵泡激素注射液获得《药品注册证书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2640957430","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640957430?lang=zh_cn&edition=full","pubTime":"2026-06-01 22:01","pubTimestamp":1780322506,"startTime":"0","endTime":"0","summary":"智通财经APP讯，丽珠医药 发布公告，近日，丽珠医药集团股份有限公司(本公司)的控股子公司珠海市丽珠单抗生物技术有限公司的药品重组人促卵泡激素注射液(本品)收到国家药品监督管理局核准签发的《药品注册证书》。截至本公告披露日，重组人促卵泡激素注射液累计直接投入的研发费用约为人民币1.217亿元。根据药监局及药品审评中心网站数据库显示，截至本公告披露日，重组人促卵泡激素注射液国内有4个进口产品及4个国产产品上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448778.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640895713","title":"丽珠医药(01513)：莱康奇塔单抗注射液上市许可申请获国家药品监督管理局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2640895713","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640895713?lang=zh_cn&edition=full","pubTime":"2026-06-01 22:00","pubTimestamp":1780322419,"startTime":"0","endTime":"0","summary":"莱康奇塔单抗注射液此次用于治疗强直性脊柱炎的上市申请已获国家药监局正式受理，是本品继银屑病适应症申请获受理并纳入优先审评后，第二项获受理的适应症。本品上市申请基于关键注册性III期临床研究，采用多中心、随机、双盲、安慰剂对照试验。截至本公告披露日，莱康奇塔单抗注射液累计直接投入的研发费用约为人民币21,693万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448777.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01513","BK1191","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172103414","title":"丽珠医药5月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1172103414","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1172103414?lang=zh_cn&edition=full","pubTime":"2026-06-01 16:49","pubTimestamp":1780303762,"startTime":"0","endTime":"0","summary":"丽珠医药集团股份有限公司于2026年6月1日发布截至2026年5月31日止的月报表。报告显示，本月公司已发行普通股总数与上月相比无增减变动，股本结构保持稳定。根据公告，丽珠医药H股上月底与本月底的已发行股份数均为299,807,117股，A股上月底与本月底亦均为588,100,054股。公司确认已符合香港联交所的公眾持股量要求，并遵守上市规则及相关法律规定。本次公告由公司秘书刘宁签署。至本月底，丽珠医药股本总数保持不变。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639627096","title":"丽珠医药(01513)选举冉永梅为第十二届董事会职工代表董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2639627096","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2639627096?lang=zh_cn&edition=full","pubTime":"2026-05-29 20:48","pubTimestamp":1780058886,"startTime":"0","endTime":"0","summary":"智通财经APP许，丽珠医药(01513)发布公告，经会议表决，选举冉永梅女士为公司第十二届董事会职工代表董事。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448016.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01513","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118321227","title":"丽珠医药宣派末期股息每10股派16.43港元，7月13日派发","url":"https://stock-news.laohu8.com/highlight/detail?id=1118321227","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1118321227?lang=zh_cn&edition=full","pubTime":"2026-05-29 20:35","pubTimestamp":1780058148,"startTime":"0","endTime":"0","summary":"丽珠医药(01513)发布末期股息更新公告，确认以港币派发的金额及汇率。公司2025年度末期股息为每10股派发现金红利14.3元人民币，经股东大会批准后，按1人民币兑1.149港元的汇率计算，折合每10股派发16.43港元。\n除净日定于2026年6月16日，为符合获取股息分派而递交股份过户文件的最后时限为2026年6月17日16:30，权益登记日为同日。股息预计于2026年7月13日派发。\n代扣所得税方面，对于非居民企业（非中国内地登记地址）股东，适用税率分别为10%或20%。香港股份过户登记处为卓佳证券登记有限公司。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"丽珠医药宣派末期股息每10股派16.43港元，7月13日派发","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639627411","title":"丽珠医药(01513)将于7月13日派发末期股息每10股14.3元","url":"https://stock-news.laohu8.com/highlight/detail?id=2639627411","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2639627411?lang=zh_cn&edition=full","pubTime":"2026-05-29 20:33","pubTimestamp":1780058031,"startTime":"0","endTime":"0","summary":"智通财经APP讯，丽珠医药(01513)发布公告，该公司将于2026年7月13日派发末期股息每10股14.3元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448004.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","VIG","BK1191","01513","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639462710","title":"丽珠医药(01513)聘任刘大平为总裁","url":"https://stock-news.laohu8.com/highlight/detail?id=2639462710","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2639462710?lang=zh_cn&edition=full","pubTime":"2026-05-29 20:31","pubTimestamp":1780057888,"startTime":"0","endTime":"0","summary":"智通财经APP讯，丽珠医药 公布，于 2025 年度股东会上，董事会重选朱保国先生、林楠棋先生及邱庆丰先生为第十二届董事会非执行董事;重选唐阳刚先生以及选举刘大平先生为第十二届董事会执行董事;及重选罗会远先生、崔丽婕女士、王智瑶女士以及选举康立女士为第十二届董事会独立非执行董事。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448002.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"丽珠医药(01513)聘任刘大平为总裁","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168777681","title":"丽珠医药宣派年度股息每股1.43元，7月13日派发","url":"https://stock-news.laohu8.com/highlight/detail?id=1168777681","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168777681?lang=zh_cn&edition=full","pubTime":"2026-05-29 20:26","pubTimestamp":1780057571,"startTime":"0","endTime":"0","summary":"丽珠医药于2026年5月29日举行股东周年大会，审议通过2025年度利润分配预案，将向全体股东每10股派发现金股利人民币14.30元（含税），折合每股1.43元。H股股息将以港币派付，按股东大会当日中国人民银行公布的人民币兑港币中间价1港元兑0.8703元人民币计算，每10股H股股息约16.43港元（含税）。在预扣税安排上，向H股非居民企业股东派息时将代扣代缴10%企业所得税；外籍个人股东暂免征收个人所得税。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"丽珠医药宣派年度股息每股1.43元，7月13日派发","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132212216","title":"丽珠医药2026年4月股份变动月报：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1132212216","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132212216?lang=zh_cn&edition=full","pubTime":"2026-05-06 16:53","pubTimestamp":1778057616,"startTime":"0","endTime":"0","summary":"丽珠医药于2026年5月6日发布2026年4月股份变动月报。报告期为2026年4月1日至2026年4月30日。公告显示，丽珠医药截止报告期末的股本结构保持稳定，未有新增发行、购回或注销情况。公司本月发行在外股份及注册股本均未发生变化，总注册股本仍为人民币887,907,171元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143836837","title":"丽珠医药最新进展：LIAN SGP完成对越南IMP要约收购，持股升至67.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=1143836837","media":"公告速递","labels":["shareholding","merge","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143836837?lang=zh_cn&edition=full","pubTime":"2026-04-29 20:55","pubTimestamp":1777467357,"startTime":"0","endTime":"0","summary":"丽珠医药集团披露，其全资子公司 LIAN SGP HOLDING PTE.LTD. 已结束对越南上市企业 Imexpharm Corporation的公开要约收购。根据越南国家证券委员会相关规定，LIAN SGP 此次要约收购的价格为每股 57,400 越南盾，对应约人民币 15.37 元。要约期间结束后，LIAN SGP 实际收购 104,545,781 股，占 IMP 注册资本的 67.87%，相当于有表决权股份的 67.88%。截至公告日，丽珠医药董事会成员包括执行董事唐阳刚、非执行董事朱保国（董事长）等多人，信息披露符合监管要求。公司将继续跟进交易后续事宜并依法履行信息披露义务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01513"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.livzon.com.cn","stockEarnings":[{"period":"1week","weight":-0.0537},{"period":"1month","weight":-0.045},{"period":"3month","weight":-0.0352},{"period":"6month","weight":-0.0811},{"period":"1year","weight":-0.2741},{"period":"ytd","weight":-0.0643}],"compareEarnings":[{"period":"1week","weight":-0.0071},{"period":"1month","weight":0.037},{"period":"3month","weight":-0.007},{"period":"6month","weight":-0.0462},{"period":"1year","weight":0.0117},{"period":"ytd","weight":-0.0062}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"丽珠医药集团股份有限公司是一家主要从事医药产品的研发、生产及销售业务的中国公司。该公司的主要业务包括化学制剂、生物制品、原料药及中间体、中药制剂、诊断试剂和设备，以及商业发展和职能管理。该公司的主要产品品牌包括“壹丽安”（艾普拉唑肠溶片及注射用艾普拉唑钠）、“丽珠得乐”（枸橼酸铋钾）系列产品、“丽倍乐”（雷贝拉唑钠肠溶胶囊）、“维三联”（枸橼酸铋钾片/替硝唑片/克拉霉素片）、“贝依”（注射用醋酸亮丙瑞林微球）、“丽申宝”（注射用尿促卵泡素）、“乐宝得”（注射用尿促性素）、“丽福康”（注射用伏立康唑）等。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.416667,"avgChangeRate":0.001127},{"month":2,"riseRate":0.538462,"avgChangeRate":0.025406},{"month":3,"riseRate":0.538462,"avgChangeRate":0.02244},{"month":4,"riseRate":0.692308,"avgChangeRate":0.031866},{"month":5,"riseRate":0.384615,"avgChangeRate":0.007594},{"month":6,"riseRate":0.461538,"avgChangeRate":-0.00234},{"month":7,"riseRate":0.461538,"avgChangeRate":-0.010332},{"month":8,"riseRate":0.461538,"avgChangeRate":-0.002054},{"month":9,"riseRate":0.454545,"avgChangeRate":0.011927},{"month":10,"riseRate":0.363636,"avgChangeRate":-0.019818},{"month":11,"riseRate":0.583333,"avgChangeRate":0.034244},{"month":12,"riseRate":0.5,"avgChangeRate":-0.008144}],"exchange":"SEHK","name":"丽珠医药","nameEN":"LIVZON PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"丽珠医药(01513)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供丽珠医药(01513)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"丽珠医药,01513,丽珠医药股票,丽珠医药股票老虎,丽珠医药股票老虎国际,丽珠医药行情,丽珠医药股票行情,丽珠医药股价,丽珠医药股市,丽珠医药股票价格,丽珠医药股票交易,丽珠医药股票购买,丽珠医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"丽珠医药(01513)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供丽珠医药(01513)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}